June 10, 2015 - Cordis Corp. announced the launch of the new Elitecross support catheter in the United States and Outback Elite re-entry catheter in the United States, Europe and Japan. This expands the Cordis Crossing Portfolio for treatment of chronic total occlusions (CTO), a suite of specialty and workhorse solutions designed to support physicians in crossing the most complex lesions.
A CTO occurs when the accumulation of plaque becomes so severe that it results in a complete or nearly complete blockage of the vessel. When this occurs, physicians must find a way to cross the occlusion in order to complete treatment of the lesion using interventional techniques.
"New and dedicated CTO crossing wires, re-entry devices and crossing catheters, combined with advancing technique have led to a significant improvement in success rates of CTO treatment in recent years," said Jihad Mustapha, M.D., FACC, FSCAI, director of heart and vascular at Metro Health Hospital in Wyoming, Michigan. "The expanded Cordis Crossing portfolio enables physicians to further improve treatment success, and deliver the best possible care to the patients that rely on us every day."
The Cordis Crossing Portfolio reduces the complexity of challenging cases and provides a comprehensive crossing solution of specialty and workhorse devices. The new Elitecross support catheter features a braided shaft, tapered tip, lubricious hydrophilic coating and ultra low-friction inner lumen to enhance trackability over the guidewire. The device is designed to provide additional support to the distal portion of diagnostic or interventional devices, and is compatible with the Frontrunner XP CTO catheter as well as other ancillary devices.
The redesigned Outback Elite re-entry catheter enables faster and more precise re-entry into the true lumen in the most challenging cases, and represents the first ever re-entry device available in Japan. The device was redesigned with an ergonomic handle and torque control location, enabling single-handed operation by the user. The addition of an 80 cm shaft length will aid in optimizing procedures by reducing the length of shaft outside the patient. These new features combined with a redesigned package make the Outback Elite a more convenient, precision re-entry tool for the toughest lesions of peripheral vascular disease. In a recent study by Gandini et al., the Outback re-entry catheter was shown to have a higher success rate of precision re-entry versus manual wire techniques.
Cordis expects to launch the Elitecross in Europe and Japan in the coming months.
For more information: www.cordis.com
December 16, 2024 
